Staying hydrated, eating balanced meals, and avoiding very large portions during the clearance window supports your body's transition
Retatrutide is structurally derived from the glucagon peptide family and engineered to activate three related class B GPCR receptors involved in metabolic signaling: the GLP 1 receptor, the GIP receptor, and the glucagon receptor
The New Phase of the GLP-1 Journey When GLP-1 injections first gained attention, the focus was on weight loss
Ozempic and Wegovy are FDA-approved brand-name medications that also contain semaglutide as their API
Most patients begin noticing appetite suppression and reduced hunger within the first 12 weeks of starting GLP-1 therapy
Diabetes, obesity, peripheral arterial disease, cancer, and substance use can impact both the incidence of wounds as well as the wound healing process